{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:24:21Z","timestamp":1790346261665,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","award":["Clinician Scientist Program (grant #386-0-0 to TWR and grant #367-0-0 to KNE)"],"award-info":[{"award-number":["Clinician Scientist Program (grant #386-0-0 to TWR and grant #367-0-0 to KNE)"]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","award":["grant #2554-0-0 to HH"],"award-info":[{"award-number":["grant #2554-0-0 to HH"]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","award":["Clinician Scientist Program (grant #386-0-0 to TWR and grant #367-0-0 to KNE)"],"award-info":[{"award-number":["Clinician Scientist Program (grant #386-0-0 to TWR and grant #367-0-0 to KNE)"]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["#421769743 to PM"],"award-info":[{"award-number":["#421769743 to PM"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In current international classification systems (ICD-10, DSM5), the diagnostic criteria for psychotic disorders (e.g. schizophrenia and schizoaffective disorder) are based on symptomatic descriptions since no unambiguous biomarkers are known to date. However, when underlying causes of psychotic symptoms, like inflammation, ischemia, or tumor affecting the neural tissue can be identified, a different classification is used (\"psychotic disorder with delusions due to known physiological condition\" (ICD-10: F06.2) or psychosis caused by medical factors (DSM5)). While CSF analysis still is considered optional in current diagnostic guidelines for psychotic disorders, CSF biomarkers could help to identify known physiological conditions. In this retrospective, partly descriptive analysis of 144 patients with psychotic symptoms and available CSF data, we analyzed CSF examinations' significance to differentiate patients with specific etiological factors (F06.2) from patients with schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders (F2). In 40.3% of all patients, at least one CSF parameter was out of the reference range. Abnormal CSF-findings were found significantly more often in patients diagnosed with F06.2 (88.2%) as compared to patients diagnosed with F2 (23.8%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001). A total of 17 cases were identified as probably caused by specific etiological factors (F06.2), of which ten cases fulfilled the criteria for a <jats:italic>probable<\/jats:italic> autoimmune psychosis linked to the following autoantibodies: amphiphysin, CASPR2, CV2, LGl1, NMDA, zic4, and titin. Two cases presented with anti-thyroid tissue autoantibodies. In four cases, further probable causal factors were identified: COVID-19, a frontal intracranial tumor, multiple sclerosis (n\u2009=\u20092), and neurosyphilis. Twenty-one cases remained with \"no reliable diagnostic classification\". Age at onset of psychotic symptoms differed between patients diagnosed with F2 and F06.2 (<jats:italic>p<\/jats:italic>\u2009=\u20090.014), with the latter group being older (median: 44 vs. 28\u00a0years). Various CSF parameters were analyzed in an exploratory analysis, identifying pleocytosis and oligoclonal bands (OCBs) as discriminators (F06.2 vs. F2) with a high specificity of\u2009&gt;\u200996% each. No group differences were found for gender, characteristics of psychotic symptoms, substance dependency, or family history. This study emphasizes the great importance of a detailed diagnostic workup in diagnosing psychotic disorders, including CSF analysis, to detect possible underlying pathologies and improve treatment decisions.<\/jats:p>","DOI":"10.1038\/s41598-021-86170-w","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T10:03:41Z","timestamp":1617098621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cerebrospinal fluid findings in patients with psychotic symptoms\u2014a retrospective analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Tim W.","family":"Rattay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Vittore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idil","family":"Cebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"T\u00fcnnerhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Ioanna","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"von der Ehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Vonderschmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias L.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazar","family":"Al Barazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Zeltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin N.","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Wildgruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"86170_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2018.1555376","author":"J Steiner","year":"2018","unstructured":"Steiner, J. et al. Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment. World J. Biol. Psychiat. https:\/\/doi.org\/10.1080\/15622975.2018.1555376 (2018).","journal-title":"World J. Biol. Psychiat."},{"key":"86170_CR2","unstructured":"APA. Diagnostic and statistical manual of mental disorders: DSM-5\u2122, 5th ed. (American Psychiatric Publishing, Inc., 2013)."},{"key":"86170_CR3","unstructured":"Dilling, H. Internationale klassifikation psychischer st\u00f6rungen. (2015)."},{"key":"86170_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00115-019-0700-z","volume":"90","author":"D Endres","year":"2019","unstructured":"Endres, D. et al. Autoantik\u00f6rper-assoziierte schizophreniforme Psychosen: klinische Symptomatik. Nervenarzt 90, 547\u2013563 (2019).","journal-title":"Nervenarzt"},{"key":"86170_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15, 391\u2013404 (2016).","journal-title":"Lancet Neurol."},{"key":"86170_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-59380-6","volume-title":"S3-Leitlinie Schizophrenie","author":"W Gaebel","year":"2019","unstructured":"Gaebel, W., Hasan, A. & Falkai, P. S3-Leitlinie Schizophrenie (Springer, 2019)."},{"key":"86170_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fnhum.2015.00476","volume":"9","author":"D Endres","year":"2015","unstructured":"Endres, D. et al. Immunological findings in psychotic syndromes: a tertiary care hospital\u2019s CSF sample of 180 patients. Front. Hum. Neurosci. 9, 476. https:\/\/doi.org\/10.3389\/fnhum.2015.00476 (2015).","journal-title":"Front. Hum. Neurosci."},{"key":"86170_CR8","first-page":"1646","volume":"16","author":"H Lehmann-Facius","year":"1937","unstructured":"Lehmann-Facius, H. Ueber die liquordiagnose der schizophrenien. J. Mol. Med. 16, 1646\u20131648 (1937).","journal-title":"J. Mol. Med."},{"key":"86170_CR9","first-page":"63","volume":"112","author":"T Roeder-Kutsch","year":"1939","unstructured":"Roeder-Kutsch, T. Zur Frage der pathologischen Anatomie der Schizophrenie. Allg. Z. Psychiatr 112, 63 (1939).","journal-title":"Allg. Z. Psychiatr"},{"key":"86170_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","volume":"7","author":"TA Pollak","year":"2020","unstructured":"Pollak, T. A. et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry 7, 93\u2013108 (2020).","journal-title":"Lancet Psychiatry"},{"key":"86170_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00115-019-0735-1","volume":"90","author":"LT van Elst","year":"2019","unstructured":"van Elst, L. T. et al. Autoantik\u00f6rper-assoziierte schizophreniforme Psychosen: Pathophysiologie Diagnostik und Therapie. Nervenarzt 90, 745\u2013761 (2019).","journal-title":"Nervenarzt"},{"key":"86170_CR12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau, J. & Graus, F. Antibody-mediated encephalitis. N. Engl. J. Med. 378, 840\u2013851 (2018).","journal-title":"N. Engl. J. Med."},{"key":"86170_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4088\/PCC.19m02549","volume":"22","author":"J Marques","year":"2020","unstructured":"Marques, J. Organic psychosis causing secondary schizophrenia in one-fourth of a cohort of 200 patients previously diagnosed with primary schizophrenia. Primary Care Companion for CNS Disorders 22, 1. https:\/\/doi.org\/10.4088\/PCC.19m02549 (2020).","journal-title":"Primary Care Companion for CNS Disorders"},{"key":"86170_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.msard.2016.04.004","volume":"8","author":"M Marziniak","year":"2016","unstructured":"Marziniak, M. et al. Variations in multiple sclerosis practice within Europe\u2013Is it time for a new treatment guideline?. Multiple Sclerosis Relat. Disorders 8, 35\u201344 (2016).","journal-title":"Multiple Sclerosis Relat. Disorders"},{"key":"86170_CR15","doi-asserted-by":"publisher","first-page":"112725","DOI":"10.1016\/j.psychres.2019.112725","volume":"285","author":"ML Herrmann","year":"2020","unstructured":"Herrmann, M. L., Bruchner, N., Martin, P. & Wildgruber, D. Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: a case report. Psychiatry Res. 285, 112725. https:\/\/doi.org\/10.1016\/j.psychres.2019.112725 (2020).","journal-title":"Psychiatry Res."},{"key":"86170_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archneurpsyc.1951.02320080029002","volume":"66","author":"AE Scheflen","year":"1951","unstructured":"Scheflen, A. E. Malignant tumors in the institutionalized psychotic population. AMA Arch Neurol Psychiatry 66, 145\u2013155. https:\/\/doi.org\/10.1001\/archneurpsyc.1951.02320080029002 (1951).","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"86170_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/archinte.1971.00310220104015","volume":"128","author":"RJ Hart Jr","year":"1971","unstructured":"Hart, R. J. Jr. & McCurdy, P. R. Psychosis in vitamin B12 deficiency. Arch. Intern. Med. 128, 596\u2013597. https:\/\/doi.org\/10.1001\/archinte.1971.00310220104015 (1971).","journal-title":"Arch. Intern. Med."},{"key":"86170_CR18","first-page":"219","volume":"9","author":"W Nicol","year":"1933","unstructured":"Nicol, W. The relation of syphilis to mental disorder and the treatment of GPI by malaria. British J. Venereal Dis. 9, 219 (1933).","journal-title":"British J. Venereal Dis."},{"key":"86170_CR19","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jdv.12734","volume":"28","author":"M Janier","year":"2014","unstructured":"Janier, M. et al. 2014 European guideline on the management of syphilis. J. Eur. Acad. Dermatol. Venereol. 28, 1581\u20131593. https:\/\/doi.org\/10.1111\/jdv.12734 (2014).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"86170_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/wps.20001","volume":"12","author":"MS Keshavan","year":"2013","unstructured":"Keshavan, M. S. & Kaneko, Y. Secondary psychoses: an update. World Psychiatry 12, 4\u201315 (2013).","journal-title":"World Psychiatry"},{"key":"86170_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11011-013-9457-4","volume":"29","author":"GP Jordaan","year":"2014","unstructured":"Jordaan, G. P. & Emsley, R. Alcohol-induced psychotic disorder: a review. Metab. Brain Dis. 29, 231\u2013243 (2014).","journal-title":"Metab. Brain Dis."},{"key":"86170_CR22","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.3390\/ijerph16214149","volume":"16","author":"NT Pearson","year":"2019","unstructured":"Pearson, N. T. & Berry, J. H. Cannabis and psychosis through the lens of DSM-5. Int. J. Environ. Res. Public Health 16, 4149 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"86170_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/1874473711104040228","volume":"4","author":"A Fiorentini","year":"2011","unstructured":"Fiorentini, A. et al. Substance-induced psychoses: a critical review of the literature. Curr. Drug Abuse Rev. 4, 228\u2013240 (2011).","journal-title":"Curr. Drug Abuse Rev."},{"key":"86170_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10550490701861201","volume":"17","author":"JJ Mahoney III","year":"2008","unstructured":"Mahoney, J. J. III., Kalechstein, A. D., De La Garza, R. & Newton, T. F. Presence and persistence of psychotic symptoms in cocaine-versus methamphetamine-dependent participants. Am. J. Addict. 17, 83\u201398 (2008).","journal-title":"Am. J. Addict."},{"key":"86170_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols, D. E. Psychedelics. Pharmacol. Rev. 68, 264\u2013355 (2016).","journal-title":"Pharmacol. Rev."},{"key":"86170_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.62.6.865","volume":"62","author":"MS Freedman","year":"2005","unstructured":"Freedman, M. S. et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch. Neurol. 62, 865\u2013870. https:\/\/doi.org\/10.1001\/archneur.62.6.865 (2005).","journal-title":"Arch. Neurol."},{"key":"86170_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/acn3.583","volume":"5","author":"C Wilke","year":"2018","unstructured":"Wilke, C. et al. Serum neurofilament light chain is increased in hereditary spastic paraplegias. Ann. Clin. Transl. Neurol. 5, 876\u2013882. https:\/\/doi.org\/10.1002\/acn3.583 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"86170_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","volume":"17","author":"A Yilmaz","year":"2017","unstructured":"Yilmaz, A. et al. Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Exp. Rev. Mol. Diagn. 17, 761\u2013770 (2017).","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"86170_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s0006-3223(98)00043-2","volume":"44","author":"F Curtin","year":"1998","unstructured":"Curtin, F. & Schulz, P. Multiple correlations and Bonferroni\u2019s correction. Biol. Psychiat. 44, 775\u2013777. https:\/\/doi.org\/10.1016\/s0006-3223(98)00043-2 (1998).","journal-title":"Biol. Psychiat."},{"key":"86170_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-00967-3","volume":"10","author":"D Endres","year":"2020","unstructured":"Endres, D. et al. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Trans. Psychiatry 10, 1\u201320 (2020).","journal-title":"Trans. Psychiatry"},{"key":"86170_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pnpbp.2012.06.019","volume":"42","author":"K Bechter","year":"2013","unstructured":"Bechter, K. Updating the mild encephalitis hypothesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 42, 71\u201391. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.06.019 (2013).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"86170_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","volume":"44","author":"K Bechter","year":"2010","unstructured":"Bechter, K. et al. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood\u2013CSF barrier dysfunction. J. Psychiatr. Res. 44, 321\u2013330. https:\/\/doi.org\/10.1016\/j.jpsychires.2009.08.008 (2010).","journal-title":"J. Psychiatr. Res."},{"key":"86170_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000116920","volume":"33","author":"K Blennow","year":"1993","unstructured":"Blennow, K. et al. Protein analysis in cerebrospinal fluid. Eur. Neurol. 33, 134\u2013142. https:\/\/doi.org\/10.1159\/000116920 (1993).","journal-title":"Eur. Neurol."},{"key":"86170_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s004150070130","volume":"247","author":"S Haghighi","year":"2000","unstructured":"Haghighi, S. et al. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J. Neurol. 247, 616\u2013622 (2000).","journal-title":"J. Neurol."},{"key":"86170_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/qjmed\/89.3.187","volume":"89","author":"A Zeman","year":"1996","unstructured":"Zeman, A., Keir, G., Luxton, R. & Thompson, E. Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source. QJM Int. J. Med. 89, 187\u2013194 (1996).","journal-title":"QJM Int. J. Med."},{"key":"86170_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1212\/wnl.36.5.727","volume":"36","author":"P Duquette","year":"1986","unstructured":"Duquette, P. & Charest, L. Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients. Neurology 36, 727\u2013727. https:\/\/doi.org\/10.1212\/wnl.36.5.727 (1986).","journal-title":"Neurology"},{"key":"86170_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/brain\/awu405","volume":"138","author":"A Goris","year":"2015","unstructured":"Goris, A. et al. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain 138, 632\u2013643 (2015).","journal-title":"Brain"},{"key":"86170_CR38","doi-asserted-by":"crossref","unstructured":"Bacioglu, M. et al. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases. Neuron (2016).","DOI":"10.1016\/j.neuron.2016.05.018"},{"key":"86170_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","volume":"64","author":"JN Lycke","year":"1998","unstructured":"Lycke, J. N., Karlsson, J.-E., Andersen, O. & Rosengren, L. E. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 64, 402\u2013404. https:\/\/doi.org\/10.1136\/jnnp.64.3.402 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"86170_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","volume":"113","author":"MHDR Al Shweiki","year":"2019","unstructured":"Al Shweiki, M. H. D. R. et al. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. J. Psychiatric Res. 113, 137\u2013140. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.03.019 (2019).","journal-title":"J. Psychiatric Res."},{"key":"86170_CR41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"E Tan","year":"1997","unstructured":"Tan, E. et al. Range of antinuclear antibodies in \u201chealthy\u201d individuals. Arthritis Rheumatism Official J. Am. College of Rheumatol. 40, 1601\u20131611 (1997).","journal-title":"Arthritis Rheumatism Official J. Am. College of Rheumatol."},{"key":"86170_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1176\/appi.psy.48.4.286","volume":"48","author":"B Appleby","year":"2007","unstructured":"Appleby, B. Are anti-nuclear antibodies common in affective disorders? A review of the past 35 years. Psychosomatics 48, 286\u2013289. https:\/\/doi.org\/10.1176\/appi.psy.48.4.286 (2007).","journal-title":"Psychosomatics"},{"key":"86170_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0924-9338(96)82334-0","volume":"11","author":"K Schott","year":"1996","unstructured":"Schott, K. et al. Antinuclear antibodies in schizophrenia and major depressive disorder\u2014a lasting puzzle. Eur. Psychiatry 11, 263\u2013267 (1996).","journal-title":"Eur. Psychiatry"},{"key":"86170_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjschz.2015.13","volume":"1","author":"HC Van Mierlo","year":"2015","unstructured":"Van Mierlo, H. C., De Witte, L., Derksen, R. H. & Otten, H. G. The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study. NPJ Schizophrenia 1, 1\u20134 (2015).","journal-title":"NPJ Schizophrenia"},{"key":"86170_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa240","author":"RW Paterson","year":"2020","unstructured":"Paterson, R. W. et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain https:\/\/doi.org\/10.1093\/brain\/awaa240 (2020).","journal-title":"Brain"},{"key":"86170_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","volume":"7","author":"A Varatharaj","year":"2020","unstructured":"Varatharaj, A. et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7, 875\u2013882. https:\/\/doi.org\/10.1016\/S2215-0366(20)30287-X (2020).","journal-title":"Lancet Psychiatry"},{"key":"86170_CR47","doi-asserted-by":"publisher","first-page":"113254","DOI":"10.1016\/j.psychres.2020.113254","volume":"291","author":"A Parra","year":"2020","unstructured":"Parra, A. et al. Psychotic symptoms in COVID-19 patients A retrospective descriptive study. Psychiatry Res. 291, 113254. https:\/\/doi.org\/10.1016\/j.psychres.2020.113254 (2020).","journal-title":"Psychiatry Res."},{"key":"86170_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","volume":"8","author":"J Herken","year":"2017","unstructured":"Herken, J. & Pr\u00fcss, H. Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients. Front Psychiatry 8, 25. https:\/\/doi.org\/10.3389\/fpsyt.2017.00025 (2017).","journal-title":"Front Psychiatry"},{"key":"86170_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.crad.2012.07.010","volume":"68","author":"N Khandanpour","year":"2013","unstructured":"Khandanpour, N., Hoggard, N. & Connolly, D. The role of MRI and CT of the brain in first episodes of psychosis. Clin. Radiol. 68, 245\u2013250 (2013).","journal-title":"Clin. Radiol."},{"key":"86170_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.msard.2016.12.012","volume":"12","author":"CR Camara-Lemarroy","year":"2017","unstructured":"Camara-Lemarroy, C. R. et al. The varieties of psychosis in multiple sclerosis: A systematic review of cases. Multiple Sclerosis Related Disorders 12, 9\u201314. https:\/\/doi.org\/10.1016\/j.msard.2016.12.012 (2017).","journal-title":"Multiple Sclerosis Related Disorders"},{"key":"86170_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2017","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2 (2017).","journal-title":"Lancet Neurol."},{"key":"86170_CR52","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(17)32451-0","volume":"391","author":"S Nath","year":"2018","unstructured":"Nath, S. et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet 391, 1197\u20131204. https:\/\/doi.org\/10.1016\/S0140-6736(17)32451-0 (2018).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86170-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:56:45Z","timestamp":1670047005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86170-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["86170"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-86170-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7169"}}